77 results on '"Bartz-Schmidt, Karl-Ulrich"'
Search Results
2. Long-term outcomes of autologous platelet treatment for optic disc pit maculopathy
3. Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection
4. Histological findings of corneal tissue after failed phototherapeutic keratectomy in macular corneal dystrophy – a case report
5. Impact of keratoconus stage on outcome after corneal crosslinking
6. Correction to: Analysis of retinal detachment resulted from post-operative endophthalmitis treated with 23G pars Plana Vitrectomy
7. Outcomes after Descemet membrane endothelial keratoplasty over a period of 7 years at a tertiary referral center: endothelial cell density, central corneal thickness, and visual acuity
8. First results of investigations of SARS-CoV-2 RNA in human corneal tissue
9. Results of different strategies to manage complicated retinal re-detachment
10. Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods
11. SARS-CoV-2-Infektion und Auge
12. Seroprävalenz und SARS-CoV-2-Testung in Gesundheitsberufen
13. Bedeutung der Hornhautorgankultur bei Spendern mit möglicher SARS-CoV-2-Infektion
14. Erste Ergebnisse zu Untersuchungen der menschlichen Hornhaut auf SARS-CoV‑2-RNA
15. New retinal tack designs: an analysis of retention forces in human scleral tissue
16. Überraschung nach Treppensturz
17. Investigating retinal toxicity of a lutein-based dye in a model of isolated and perfused bovine retina
18. Histopathology of a retrocorneal membrane after Descemet membrane endothelial keratoplasty: a case report
19. New digital methods: remodelling the harms tangent scale setting
20. Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
21. pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
22. Gentherapie zur Behandlung von Netzhauterkrankungen
23. Knowledge of vitreomacular traction (VMT) scenarios: Is doing nothing still a beneficial alternative and, if so, when?
24. Investigating short-term toxicity of melphalan in a model of an isolated and superfused bovine retina
25. Multimodal assessment of choroideremia patients defines pre-treatment characteristics
26. Safety evaluation of “retina implant alpha IMS”—a prospective clinical trial
27. A new kind of labyrinth-like capillary is responsible for leakage from human choroidal neovascular endothelium, as investigated by high-resolution electron microscopy
28. Investigating retinal toxicity of tempol in a model of isolated and perfused bovine retina
29. Descemet membrane endothelial keratoplasty in cases with existing scleral-sutured and iris-sutured intraocular lenses
30. Usability of a gravity- and tilt-compensated sensor with data logging function to measure posturing compliance in patients after macular hole surgery: a pilot study
31. Electroretinographic assessment of retinal function during acute exposure to normobaric hypoxia
32. Transcorneal Electrical Stimulation in Patients with Retinal Artery Occlusion: A Prospective, Randomized, Sham-Controlled Pilot Study
33. Amniotic bands as a cause of congenital anterior staphyloma
34. Response to: Non-invasive electrical brain stimulation induces vision restoration in patients with visual pathway damage
35. Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin
36. Electrical stimulation — a therapeutic strategy for retinal and optic nerve disease?
37. Investigating the biocompatibility of two new heavy intraocular dyes for vitreoretinal surgery with an isolated perfused vertebrate retina organ culture model and a retinal ganglion cell line
38. The effects of the intraocular dye brilliant blue G (BBG) mixed with varying concentrations of glucose on retinal function in an isolated perfused vertebrate retina
39. Visualization and follow-up of acute macular neuroretinopathy with the Spectralis® HRA+OCT device
40. Papillary capillary activation in Terson syndrome
41. The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina
42. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin®) for treatment of angoid streaks in pseudoxanthoma elasticum
43. Ultrastructural analysis of the pigment dispersion syndrome in DBA/2J mice
44. Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration
45. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT)
46. Virtual reality training improves wet-lab performance of capsulorhexis: results of a randomized, controlled study
47. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion
48. Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina
49. Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration — a report of 1 year results
50. Inner limiting membrane as membranous support in RPE sheet-transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.